SLS Borrow Market Tightens
SELLAS Life Sciences Group (SLS) has been highlighted for its elevated borrow fees within the Interactive Brokers lending platform. High borrow fees are a classic signal of a 'hard-to-borrow' stock, often reflecting intense demand from short sellers to establish or maintain positions. When borrow costs spike, it can lead to increased volatility and potential short-squeeze setups if the stock price begins to move upward. Traders should keep a close eye on share availability, as a further collapse in supply could exacerbate the current cost-to-borrow pressure.
Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.